potent, selective, oral gamma-secretase modulator

PD effect on A-beta in model, well-tol. in 2 species

from optimization of prior ligand

ACS Med. Chem. Lett., May 1, 2020

Roche, Basel, CH

RO7185876 is a gamma-secretase modulator (GSM) intended for treatment of Alzheimer’s disease. GSMs, which act by stabilizing the enzyme/substrate complex to promote generation of shorter peptides rather than inhibiting enzyme…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.